We advised Bioceltix and Infini ASI on the public offering
03.07.2024 Case studies Capital Markets
We provided transactional legal services in connection with the public offering of Bioceltix and Infini ASI. We offered comprehensive legal support to Bioceltix, Infini ASI, and the offering managers and bookrunners: mBank Brokerage House, Trigon Investment Banking, and Navigator Brokerage House.
The public offering of newly issued Bioceltix shares and existing Infini ASI shares was conducted via an accelerated book-building process (ABB), exempt from the requirement to prepare a prospectus. It was targeted at (i) qualified investors, (ii) no more than 149 natural or legal persons other than qualified investors, and (iii) investors who purchased shares with a total value of at least EUR 100,000—while maintaining preemptive rights for the company’s existing shareholders.
The PR/IR advisors were CCGroup sp. z o.o. and Hagen Comm sp. z o.o.
The total value of the offering exceeded PLN 60 million.
The transaction involved: Krzysztof Marczuk, Jakub Rowicki, Magdalena Szeplik, and Dawid Marciniak.
Lawyers involved in the project
You may also like
07.02.2025
Closing of the transaction of the acquisition of 49.9% in the listed company Shoper S.A. by cyber_Folks S.A.
We are pleased to announce the successful closing of another transaction for one of our key clients, cyber_Folks S.A. Once again, we provided comprehensive legal advice ...
27.01.2025
GESSEL advised Maabarot Products on the sale of 100% shares in Laboratoria Natury to Farmaceutici Procemsa
As a trusted legal advisor equipped to support clients throughout the entire investment lifecycle, we had the privilege of advising Maabarot Products Ltd., a company own...